TB

This fact sheet introduces the TB blood test, also called an Interferon Gamma Release Assay or IGRA.

The website contains the history of World TB Day and multiple resources, including web graphics, that can be used in social media updates, websites, and presentations. This website also allows TB organizations to share their World TB Day 2019 activities.The 2019 US World TB Day theme is "It’s TIME."

This 60-minute webinar reviews best practices for TB diagnosis and management for ICE detainees, the role of public health and community partners, and how care is coordinated for patients who are released.

This information sheet discusses the TB Genotyping Information Management System (TB GIMS) a secure web-based system for storing and managing genotyping data on TB patients in the United States. It explains the objectives of TB GIMS, who would be the primary users, and the different user roles and access levels. Users are categorized as super user, standard user, and restricted-access user.

This pamphlet is the introduction to a series of TB-specific cultural competency guides for the birth countries most commonly reported by foreign-born persons being treated for TB in the United States.

This report presents the Centers for Disease Control and Prevention's (CDC) updated recommendations on the use of nucleic acid amplification tests (NAA) for TB diagnosis. These revised guidelines were developed on the basis of a report by a panel of clinicians, laboratorians, and TB control officials. The panel was convened by CDC and the Association of Public Health Laboratories (APHL) and in consultation with the Advisory Council for the Elimination of TB (ACET).

This report is the annual compilation of data from World Health Organization’s (WHO) 193 member states. It provides a summary of the current status of national health and health systems, including mortality and burden of disease, causes of death, reported infectious diseases, health service coverage, risk factors, health systems resources, health expenditures, inequities, and demographic and socioeconomic statistics.

This report summarizes the external consultation on appropriate key short - and long-term priorities for addressing social determinants of HIV/AIDS, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) for the National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP) to undertake.

This report describes the investigation by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), which initially identified five confirmed cases of multidrug-resistant tuberculosis (MDR TB) in two distinct clusters, characterized by two distinct geographic locations, genotypes, and drug-susceptibility patterns in the Federated States of Micronesia. Extensive transmission had occurred among household contacts; 16 (8%) of the 205 contacts identified had confirmed or suspected MDR TB disease, and 124 (60%) had latent TB infection.

This report describes the investigation of a genotype cluster of eight tuberculosis cases in US born patients in the Detroit metropolitan area. The investigation was done by the Detroit Department of Health and Wellness Promotion, the Michigan Department of Community Health, and the Centers for Disease Control and Prevention. The first case was reported in a patient with drug-susceptible TB, who subsequently developed multidrug-resistant TB (MDR TB). Seven additional cases were reported in patients with TB genotypes matching that of the index patient.